Our Clients
Biotechnology & Pharmaceutical
Achillion Pharmaceuticals
Ambit Therapeutics
Ambrx
ARIAD Pharmaceuticals
ARYx Therapeutics
Bellicum Pharmaceuticals
BerGenBio AS
BioCryst Pharmaceuticals
Celera
Celgene
Cell Therapeutics
Celldex Therapeutics
Codexis
Corcept Therapeutics
Cylene Pharmaceuticals
Cytokinetics
Dendreon
Durect
Dyadic
Eiger BioPharmaceuticals
FibroGen
Geron
Gilead Sciences
Horizon Therapeutics
Hyperion Therapeutics
ImmunoGen
InSite Vision
InterMune
KineMed
Light Sciences Oncology
Marina Biotech
Medco Health Solutions
Medivation
NeurogesX
Novo Nordisk
OSI Pharmaceuticals
Pfizer
PTC Therapeutics
Regeneron
RegeneRx
Rigel
Targacept Corporation
Technology Vision Group
Theravance
Threshold Pharmaceuticals
Medical Device
ArthroCare
Caliper Life Sciences
IntraPace
Lumenis
Medtronic
TransMedics
Ventus Medical
VisionCare
Non Profit
The Avon Foundation for Women
The Dr. Susan Love Research Foundation
The Epilepsy Therapy Project
The Institute for OneWorld Health
The Parkinson's Disease Foundation
Venture Capital
Geolo Capital
Granite Point Capital
Montreux Equity Partners
TPG Growth
Consulting
Booz Allen Hamilton
Deloitte Recap




